431 related articles for article (PubMed ID: 9164953)
21. Trypanosoma cruzi: the effect of nitric oxide synthesis inhibition on the CD4 T cell response to the trans-sialidase superfamily.
Millar AE; Kahn SJ
Exp Parasitol; 2000 Feb; 94(2):84-91. PubMed ID: 10673344
[TBL] [Abstract][Full Text] [Related]
22. Effect of a combination DNA vaccine for the prevention and therapy of Trypanosoma cruzi infection in mice: role of CD4+ and CD8+ T cells.
Limon-Flores AY; Cervera-Cetina R; Tzec-Arjona JL; Ek-Macias L; Sánchez-Burgos G; Ramirez-Sierra MJ; Cruz-Chan JV; VanWynsberghe NR; Dumonteil E
Vaccine; 2010 Oct; 28(46):7414-9. PubMed ID: 20850536
[TBL] [Abstract][Full Text] [Related]
23. Isolation from Trypanosoma cruzi-infected mice of CD8+, MHC-restricted cytotoxic T cells that lyse parasite-infected target cells.
Nickell SP; Stryker GA; Arevalo C
J Immunol; 1993 Feb; 150(4):1446-57. PubMed ID: 8432987
[TBL] [Abstract][Full Text] [Related]
24. [Immune response to Trypanosoma cruzi. An approach to the pathogenesis of Chagas' disease].
Braun M; de Titto E
Acta Physiol Pharmacol Latinoam; 1985; 35(1):1-47. PubMed ID: 2932884
[TBL] [Abstract][Full Text] [Related]
25. [Experimental Chagas' disease: I. Study of different immunization conditions in the infection course].
Introini MV; Basso B; Moretti E
Bol Chil Parasitol; 1998; 53(3-4):45-51. PubMed ID: 10413878
[TBL] [Abstract][Full Text] [Related]
26. Identification of Trypanosoma cruzi trans-sialidase family members as targets of protective CD8+ TC1 responses.
Wizel B; Nunes M; Tarleton RL
J Immunol; 1997 Dec; 159(12):6120-30. PubMed ID: 9550413
[TBL] [Abstract][Full Text] [Related]
27. Paraflagellar rod protein-specific CD8+ cytotoxic T lymphocytes target Trypanosoma cruzi-infected host cells.
Wrightsman RA; Luhrs KA; Fouts D; Manning JE
Parasite Immunol; 2002 Aug; 24(8):401-12. PubMed ID: 12406194
[TBL] [Abstract][Full Text] [Related]
28. Acute Trypanosoma cruzi infection: IL-12, IL-18, TNF, sTNFR and NO in T. rangeli-vaccinated mice.
Basso B; Cervetta L; Moretti E; Carlier Y; Truyens C
Vaccine; 2004 May; 22(15-16):1868-72. PubMed ID: 15121297
[TBL] [Abstract][Full Text] [Related]
29. Paraflagellar rod proteins administered with alum and IL-12 or recombinant adenovirus expressing IL-12 generates antigen-specific responses and protective immunity in mice against Trypanosoma cruzi.
Wrightsman RA; Manning JE
Vaccine; 2000 Jan; 18(14):1419-27. PubMed ID: 10618540
[TBL] [Abstract][Full Text] [Related]
30. Regulatory role of Toll-like receptor 2 during infection with Trypanosoma cruzi.
Ropert C; Gazzinelli RT
J Endotoxin Res; 2004; 10(6):425-30. PubMed ID: 15588426
[TBL] [Abstract][Full Text] [Related]
31. Immunization with an engineered mutant trans-sialidase highly protects mice from experimental Trypanosoma cruzi infection: a vaccine candidate.
Fontanella GH; De Vusser K; Laroy W; Daurelio L; Nocito AL; Revelli S; Contreras R
Vaccine; 2008 May; 26(19):2322-34. PubMed ID: 18403070
[TBL] [Abstract][Full Text] [Related]
32. Anatomical route of invasion and protective mucosal immunity in Trypanosoma cruzi conjunctival infection.
Giddings OK; Eickhoff CS; Smith TJ; Bryant LA; Hoft DF
Infect Immun; 2006 Oct; 74(10):5549-60. PubMed ID: 16988230
[TBL] [Abstract][Full Text] [Related]
33. GP 50/55, a membrane antigen of Trypanosoma cruzi involved in autoimmunity and immunosuppression.
Hernández-Munaín C; De Diego JL; Bonay P; Gironés N; Fresno M
Biol Res; 1993; 26(1-2):209-18. PubMed ID: 7670533
[TBL] [Abstract][Full Text] [Related]
34. Trypanosoma cruzi: immunological consequences of parasite modification of host cells.
Ribeiro Dos Santos R; Hudson L
Clin Exp Immunol; 1980 Apr; 40(1):36-41. PubMed ID: 6771080
[TBL] [Abstract][Full Text] [Related]
35. Involvement of nitric oxide (NO) and TNF-alpha in the oxidative stress associated with anemia in experimental Trypanosoma cruzi infection.
Malvezi AD; Cecchini R; de Souza F; Tadokoro CE; Rizzo LV; Pinge-Filho P
FEMS Immunol Med Microbiol; 2004 May; 41(1):69-77. PubMed ID: 15094169
[TBL] [Abstract][Full Text] [Related]
36. Trypanosoma cruzi-infected macrophages are defective in major histocompatibility complex class II antigen presentation.
La Flamme AC; Kahn SJ; Rudensky AY; Van Voorhis WC
Eur J Immunol; 1997 Dec; 27(12):3085-94. PubMed ID: 9464791
[TBL] [Abstract][Full Text] [Related]
37. Susceptibility of beta 2-microglobulin-deficient mice to Trypanosoma cruzi infection.
Tarleton RL; Koller BH; Latour A; Postan M
Nature; 1992 Mar; 356(6367):338-40. PubMed ID: 1549177
[TBL] [Abstract][Full Text] [Related]
38. Dendritic cells devoid of IL-10 induce protective immunity against the protozoan parasite Trypanosoma cruzi.
Alba Soto CD; Solana ME; Poncini CV; Pino-Martinez AM; Tekiel V; González-Cappa SM
Vaccine; 2010 Oct; 28(46):7407-13. PubMed ID: 20850535
[TBL] [Abstract][Full Text] [Related]
39. Challenge of Trypanosoma cruzi chronically infected mice with trypomastigotes activates the immune system and reduces subpatent parasitemia levels.
Marinho CR; Bastos KR; Sardinha LR; Grisotto MG; Lima MR; Alvarez JM
J Parasitol; 2004 Jun; 90(3):516-23. PubMed ID: 15270095
[TBL] [Abstract][Full Text] [Related]
40. [Immunologic protection against Chagas disease. Independent effects upon infection, dissemination and lesions of Trypanosoma cruzi].
Basombrio MA; Mora MC; Segura MA
Medicina (B Aires); 1989; 49(3):191-6. PubMed ID: 2518641
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
